<bill session="115" type="s" number="2842" updated="2023-01-11T13:42:13Z">
  <state datetime="2018-05-22">REPORTED</state>
  <status>
    <unknown datetime="2018-05-22"/>
  </status>
  <introduced datetime="2018-05-15"/>
  <titles>
    <title type="display">Opioid Addiction Recovery Fraud Prevention Act of 2018</title>
    <title type="official" as="introduced">A bill to prohibit the marketing of bogus opioid treatment programs or products.</title>
    <title type="short" as="reported to senate">Opioid Addiction Recovery Fraud Prevention Act of 2018</title>
    <title type="short" as="introduced">Opioid Addiction Recovery Fraud Prevention Act of 2018</title>
  </titles>
  <sponsor bioguide_id="C001047"/>
  <cosponsors>
    <cosponsor bioguide_id="B000944" joined="2018-05-23"/>
    <cosponsor bioguide_id="C001113" joined="2018-05-15"/>
    <cosponsor bioguide_id="M001183" joined="2018-08-21"/>
    <cosponsor bioguide_id="N000032" joined="2018-06-27"/>
    <cosponsor bioguide_id="S001198" joined="2018-05-21"/>
  </cosponsors>
  <actions>
    <action datetime="2018-05-15">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2018-05-15" state="REFERRED">
      <text>Read twice and referred to the Committee on Commerce, Science, and Transportation.</text>
    </action>
    <action datetime="2018-05-22" state="REPORTED">
      <text>Committee on Commerce, Science, and Transportation. Ordered to be reported with an amendment in the nature of a substitute favorably.</text>
    </action>
    <action datetime="2018-06-27">
      <text>Committee on Commerce, Science, and Transportation. Reported by Senator Thune with an amendment in the nature of a substitute. With written report No. 115-285.</text>
    </action>
    <calendar datetime="2018-06-27" calendar="Senate Legislative" under="General Orders" number="490">
      <text>Placed on Senate Legislative Calendar under General Orders. Calendar No. 490.</text>
    </calendar>
  </actions>
  <committees>
    <committee code="SSCM" name="Senate Commerce, Science, and Transportation" subcommittee="" activity="Reporting, Markup, Referral"/>
  </committees>
  <relatedbills>
    <bill session="115" type="h" number="6" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Commerce"/>
    <term name="Civil actions and liability"/>
    <term name="Consumer affairs"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Drug, alcohol, tobacco use"/>
    <term name="Federal preemption"/>
    <term name="Fraud offenses and financial crimes"/>
    <term name="Health promotion and preventive care"/>
    <term name="Marketing and advertising"/>
    <term name="State and local government operations"/>
  </subjects>
  <amendments>
    <amendment number="s2251"/>
  </amendments>
  <summary date="2019-09-06T13:41:26Z" status="Introduced in Senate">Opioid Addiction Recovery Fraud Prevention Act of 2018

This bill prohibits deceptive representation regarding the cost, price, efficacy, performance, benefit, risk, or safety of opioid treatment programs or products.</summary>
  <committee-reports>
    <report>S. Rept. 115-285</report>
  </committee-reports>
</bill>
